StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) stock

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3031% below fair value
$2.45−0.28 (-10.26%)

Close on Nov 19, 2026Market cap $140.10MP/E –Yield –

Abeona Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Abeona Therapeutics's gross profit for the twelve months ending Jun 30, 2026 was $17.12M. For fiscal 2025 it was $4.29M, up 363.6% from the year before. The highest annual figure on record is $4.29M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.29M+363.6%
FY2014Dec 31, 2014$925.00K-51.7%
FY2013Dec 31, 2013$1.92M-53.7%
FY2012Dec 31, 2012$4.14M+144.6%
FY2011Dec 31, 2011$1.69M+395.9%
FY2010Dec 31, 2010$341.00K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.20M–
Q1 FY2026Mar 31, 2026$6.02M–
Q4 FY2025Dec 31, 2025$4.38M–
Q3 FY2025Sep 30, 2025-$488.00K–

More Abeona Therapeutics figures

See a number that looks wrong?